Global Ranitidine (Zantac) Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Ranitidine (Zantac) Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Ranitidine (Zantac) report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Ranitidine (Zantac) market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Hospital Pharmacy and Retail Pharmacy are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Ranitidine (Zantac) industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Ranitidine (Zantac) key manufacturers include Sanofi-Aventis, GlaxoSmithKline, Hi-Tech Pharmacal Co., Sun Pharma, Mylan Pharmaceuticals Inc. (and Mylan Laboratories), Dr. Reddy’s Laboratories Inc., Sandoz Inc. (part of Novartis AG), Strides (and Strides Arcolab international) and Geri-Care Pharmaceuticals, etc. Sanofi-Aventis, GlaxoSmithKline, Hi-Tech Pharmacal Co. are top 3 players and held % sales share in total in 2022.
Ranitidine (Zantac) can be divided into Ranitidine Capsule, Ranitidine Oral Tablet, Ranitidine Injectable Solution and Ranitidine Oral Syrup, etc. Ranitidine Capsule is the mainstream product in the market, accounting for % sales share globally in 2022.
Ranitidine (Zantac) is widely used in various fields, such as Hospital Pharmacy, Retail Pharmacy and Online Pharmacy,, etc. Hospital Pharmacy provides greatest supports to the Ranitidine (Zantac) industry development. In 2022, global % sales of Ranitidine (Zantac) went into Hospital Pharmacy filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Ranitidine (Zantac) market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Sanofi-Aventis
GlaxoSmithKline
Hi-Tech Pharmacal Co.
Sun Pharma
Mylan Pharmaceuticals Inc. (and Mylan Laboratories)
Dr. Reddy’s Laboratories Inc.
Sandoz Inc. (part of Novartis AG)
Strides (and Strides Arcolab international)
Geri-Care Pharmaceuticals
PAI Holdings, LLC
Teva Pharmaceuticals
Granules Pharmaceuticals Inc.
Glenmark Pharmaceuticals (and Glenmark Generics)
Apotex Inc. (and Apotex Corporation)
Hikma Pharmaceuticals (West-ward Pharmaceuticals)
Segment by Type
Ranitidine Capsule
Ranitidine Oral Tablet
Ranitidine Injectable Solution
Ranitidine Oral Syrup
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Ranitidine (Zantac) market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Ranitidine (Zantac), product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Ranitidine (Zantac) industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Ranitidine (Zantac) in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Ranitidine (Zantac) introduction, etc. Ranitidine (Zantac) Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Ranitidine (Zantac) market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
North America, Europe and Asia Pacific are the key regions for Ranitidine (Zantac) industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Ranitidine (Zantac) key manufacturers include Sanofi-Aventis, GlaxoSmithKline, Hi-Tech Pharmacal Co., Sun Pharma, Mylan Pharmaceuticals Inc. (and Mylan Laboratories), Dr. Reddy’s Laboratories Inc., Sandoz Inc. (part of Novartis AG), Strides (and Strides Arcolab international) and Geri-Care Pharmaceuticals, etc. Sanofi-Aventis, GlaxoSmithKline, Hi-Tech Pharmacal Co. are top 3 players and held % sales share in total in 2022.
Ranitidine (Zantac) can be divided into Ranitidine Capsule, Ranitidine Oral Tablet, Ranitidine Injectable Solution and Ranitidine Oral Syrup, etc. Ranitidine Capsule is the mainstream product in the market, accounting for % sales share globally in 2022.
Ranitidine (Zantac) is widely used in various fields, such as Hospital Pharmacy, Retail Pharmacy and Online Pharmacy,, etc. Hospital Pharmacy provides greatest supports to the Ranitidine (Zantac) industry development. In 2022, global % sales of Ranitidine (Zantac) went into Hospital Pharmacy filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Ranitidine (Zantac) market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Sanofi-Aventis
GlaxoSmithKline
Hi-Tech Pharmacal Co.
Sun Pharma
Mylan Pharmaceuticals Inc. (and Mylan Laboratories)
Dr. Reddy’s Laboratories Inc.
Sandoz Inc. (part of Novartis AG)
Strides (and Strides Arcolab international)
Geri-Care Pharmaceuticals
PAI Holdings, LLC
Teva Pharmaceuticals
Granules Pharmaceuticals Inc.
Glenmark Pharmaceuticals (and Glenmark Generics)
Apotex Inc. (and Apotex Corporation)
Hikma Pharmaceuticals (West-ward Pharmaceuticals)
Segment by Type
Ranitidine Capsule
Ranitidine Oral Tablet
Ranitidine Injectable Solution
Ranitidine Oral Syrup
Segment by Application
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Ranitidine (Zantac) market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Ranitidine (Zantac), product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Ranitidine (Zantac) industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Ranitidine (Zantac) in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Ranitidine (Zantac) introduction, etc. Ranitidine (Zantac) Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Ranitidine (Zantac) market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices